Brenda Bondesen

Brenda Bondesen currently serves as Senior Director of Research Indication Strategy and Project Lead at Elanco, with a career spanning over a decade in the pharmaceutical and biotechnology sectors. Prior roles include Senior Director of New Product Strategy and Planning at Elanco, Director of Pharmaceutical Lead Sourcing at Boehringer Ingelheim, and Director of Biology at Merial, where Brenda drove advancements in animal health through strategic collaborations and innovative research. Brenda's early career at Emory University included management of the Emory Chemical Biology Discovery Center and post-doctoral research in pharmacology. Academic credentials include a PhD in Biochemistry, Cell and Developmental Biology from Emory University and a BS in Chemistry from Davidson College.